PBS dispute could see MS patients pay $33k a year for crucial drugs

AI justification

Denial of affordable MS medication violates health rights and creates severe financial hardship | The potential denial of affordable MS medication represents a severe violation of health rights and human dignity, with catastrophic financial consequences for patients. While the dispute may eventually drive systemic improvements in drug pricing transparency, the immediate harm to vulnerable patients is overwhelmingly negative and demands urgent intervention.